There will always be challenges for the pharmaceutical industry where sustainability is concerned, but it needn’t be a bitter pill to swallow.
From complex medication requiring specific packaging to tight production schedules, the industry faces stubborn obstacles in ensuring that it improves the wellbeing and health of humans while not harming the planet.
February 18, 2020 – For the 16th consecutive year, Novo Nordisk has published its integrated 2019 Annual report detailing the company’s year-end performance.
Still accounting for financial, social and environmental performance, the Management Review details the company’s progression in four new dimensions of strategic aspirations for 2025: purpose and sustainability; innovation and therapeutic focus; commercial execution; and financials.
More than one million students nationwide enabled to advance healthy living in their communities.
SILVER SPRING, Md., February 4, 2020 /3BL Media/ - Novo Nordisk and Discovery Education—the global leader in standards-aligned digital curriculum resources, engaging content, and professional learning for K-12 classrooms—announced the winners of the annual Super Health, Super YouCommunity Challenge. Three U.S.
Novo Nordisk has published its integrated 2018 Annual Report detailing the company’s year-end performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. This is the company’s 15th integrated report.
Case study highlights how Novo Nordisk is working to change the narrative and harmful social norms around obesity in the U.S.
BOSTON, November 8, 2018 /3BL Media/ – In a new case study, the Shared Value Initiative spotlights Novo Nordisk as a leading example of a company that has found a business opportunity in helping to solve a pressing social issue.
Novo Nordisk, a global healthcare company specialising in diabetes, obesity and other serious chronic diseases, published its Annual Report 2017 online today at novonordisk.com/annualreport. It is the company's fourteenth integrated annual report accounting for the company's financial, social and environmental performance.
Companies are uniquely positioned to drive change around social norms by using their brand credibility, marketing expertise, reach, and access to key influencers, among other assets. Companies can create significant, lasting social change by shifting harmful social norms. But why should companies invest in changing social norms, and what are the practical steps to starting this process?
HOUSTON, October 18, 2016 /3BL Media/ - The National Diversity Council is proud to present “Leading While Diverse: The Case for Diversity in Corporate Governance,” a comprehensive research report ranking top pharmaceutical companies based on their diversity in executive positions and boards of directors. The reputation of multinational pharmaceutical companies is currently one of the lowest, second only to health insurance companies.